Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5850888 | 0.84 | SRC (0.46) | SRCL3MBTL1TDP1LTA4HTSHR | |
| SCHEMBL11277910 | 0.80 | L3MBTL1 (0.46) | SRCL3MBTL1TDP1LTA4HTSHR | |
| SCHEMBL28824848 | 0.78 | SRC (0.41) | SRCL3MBTL1TDP1LTA4HTSHR | |
| SCHEMBL28457436 | 0.78 | SRC (0.50) | SRCL3MBTL1TDP1LTA4HTSHR | |
| SCHEMBL40604 | 0.78 | SRC (0.50) | SRCL3MBTL1TDP1LTA4HTSHR | |
| SCHEMBL789906 | 0.77 | MEN1 (0.52) | L3MBTL1LTA4HHTTMEN1KMT2A | |
| SCHEMBL11441635 | 0.77 | CA4 (0.42) | SRCL3MBTL1TDP1LTA4HTSHR | |
| SCHEMBL790225 | 0.75 | CA1 (0.52) | L3MBTL1TDP1LTA4HTSHRHSD17B10 | |
| SCHEMBL790308 | 0.75 | CYP1A2 (0.40) | MEN1KMT2AHPGD | |
| SCHEMBL790223 | 0.75 | CYP3A4 (0.54) | TDP1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108091439-B | Flame-retardant fire-resistant solar photovoltaic cable | 扬州曙光电缆股份有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-108154960-B | Flame-retardant fire-resistant anti-interference marine intrinsic safety instrument cable | 扬州曙光电缆股份有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-108198655-B | Flame-retardant fire-resistant marine intrinsic safety instrument cable | 扬州曙光电缆股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-115011094-A | Efficient flame-retardant polylactic acid composite material and preparation method thereof | 深圳市一族科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-111961252-B | Fire retardant phenylphosphonyl methyl silicone cage-shaped ester amine compound and preparation method thereof | 苏州科技大学 | 2022-04-26 | — | — | CN | claimed |
| CN-113336898-A | Preparation method of styrene-free flame-retardant unsaturated polyester resin | 中国科学技术大学 | 2021-09-03 | — | — | CN | claimed |
| CN-111961252-A | Fire retardant phenylphosphonyl methyl silicone cage-shaped ester amine compound and preparation method thereof | 苏州科技大学 | 2020-11-20 | — | — | CN | claimed |
| CN-111808132-A | Method for continuously and rapidly preparing N-phenyl thiophosphoryl dichloride by using microreactor | 西南科技大学 | 2020-10-23 | — | — | CN | claimed |
| EP-2828278-A1 | METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS | Alios Biopharma, Inc. (US) | 2015-01-28 | — | — | EP | claimed |
| US-8895723-B2 | Methods of preparing substituted nucleotide analogs | ALIOS BIOPHARMA, INC. (US) | 2014-11-25 | — | — | US | claimed |
| US-20130281687-A1 | METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS | VERTEX PHARMACEUTICALS INCORPORATED | 2013-10-24 | — | — | US | claimed |
| WO-2013142125-A1 | METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2013-09-26 | — | — | WO | claimed |
| US-20130253181-A1 | METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS | VERTEX PHARMACEUTICALS INC. (US) | 2013-09-26 | — | — | US | claimed |
| CN-119264182-A | Compound, preparation method thereof, resin material and application thereof | 珠海莫界科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-108091439-B | Flame-retardant fire-resistant solar photovoltaic cable | 扬州曙光电缆股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-108154960-B | Flame-retardant fire-resistant anti-interference marine intrinsic safety instrument cable | 扬州曙光电缆股份有限公司 | 2024-01-23 | — | — | CN | disclosed |
| US-4156663-A | 260/857 R | KANEBO, LTD. (JP) | 1979-05-29 | — | — | US | disclosed |
| US-4152347-A | REINFORCING AGENTS IN VULCANIZABLE RUBBER MIXTURES WHICH CONTAIN A SILICA FILLER | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-05-01 | — | — | US | disclosed |
| US-4072658-A | FLAME RETARDANTS | KANEBO, LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
| US-4039635-A | Soil fungicidal phosphorothioate | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130253181-A1 | METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS | NUDT1, PNP, TYMP | SRC 4260/4885L3MBTL1 787/4885TDP1 216/4885 |
| US-20130281687-A1 | METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS | NUDT1, PNP, TYMP | SRC 4260/4885L3MBTL1 787/4885TDP1 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.